Oncocross Co., Ltd. (KOSDAQ:382150)

South Korea · Delayed Price · Currency is KRW

10,890

-430 (-3.80%)

Jul 21, 2025, 3:30 PM KST

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Drugs	91.52M	Log In
Drugs Growth	-39.08%	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
South Korea	91.52M	Log In
South Korea Growth	-39.08%	Log In